Treatment Registry
TR-0117 ActiveRecorded September 2, 2026

Compounded semaglutide

Sold by Pallas Health · every compounded semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$139

Medication · First month$139
Consultation fee · first month only$0

Added from the figures recorded below.

Price

TermPer monthCharged today
First monthAdvertised

Compounded Semaglutide $139 first month · then $199/mo avg

source

Per month$139Charged today$139
Every 12 weeks

Compounded semaglutide: $139 for your first month, then $597 every 12 weeks ($199/mo average).

source

Per month$199Charged today$597
Enroll with Pallas Health

This is a paid link. If you enroll through it, Treatment Registry may earn a commission. It does not change what we record, and it does not change the price you pay.

History

  1. September 2, 2026$139
  2. September 2, 2026$139
  • September 2, 2026Entry added to the register

Sourcing and terms

PharmacyNot disclosed
StatesAll 50 states
PrescriberBoth
Cancellation“Cancel anytime.”
MembershipNot disclosed
Consult fee$0. Pallas says “Compounded plan prices include provider care, ongoing check-ins, and care-team messaging — no separate membership fee.” No separate consultation charge is named.

Recorded from pallashealth.co. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026After the first month, Pallas bills $597 every 12 weeks rather than monthly. The $199 it advertises is Pallas's own average across those 12 weeks, so no single month is ever billed at that price. Provider care, check-ins and care-team messaging are included, and there is no separate membership fee.
  2. 2. September 2, 2026Pallas calls the plan Compounded Semaglutide and never says whether it ships as a vial or a pen.

2 further notes concern other Pallas Health programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0117
Readings
2

Related records

What else Pallas Health sells

All Pallas Health programs and terms

Compounded semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 298 records of the same molecule.

Side by side

Cite this entry

Treatment Registry. (2026). Pallas Health compounded semaglutide (TR-0117). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0117

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.